A few weeks ago, we wrote about a positive test for latent tuberculosis and treating that infection with antibiotics. On the heels of that column, we received some follow-up questions from readers.

A team of scientists led by Oxford University have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis. The researchers have identified new ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease. In the new study, a team ...

CAMBRIDGE, MA -- A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease. In the ...

Saint Louis University's Center for Vaccine Development has received a $2.9 million award from the Bill & Melinda Gates Foundation to study a new tuberculosis vaccine. With the award, Daniel Hoft, M.D ...

While all eyes have been focused on the race to develop a COVID-19 vaccine, other researchers have been furiously working on another way to defeat the coronavirus. It's a vaccine with a very long ...

Though tuberculosis is rare in the United States as compared to developing countries, the region has some of the highest rates in the state.

TOKYO, Feb. 2, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million (1) ) in six R&D projects ...

More than 50 latent TB cases and three active infections prompt Riordan High School to halt in‑person classes and expand testing in San Francisco.